Toxicity Outcomes at 18 Months for Cs-131 Low-Dose-Rate Prostate Brachytherapy Compared to I-125 and Pd-103

被引：0
|
作者：
DePaoli, B. [1 ]
McVorran, S. M. [2 ]
Case, M. J. [3 ]
Khaleghi, S. [3 ]
Li, H. [3 ]
Marshall, D. T. [1 ]
机构：
[1] Med Univ South Carolina, Hollings Canc Ctr, Charleston, SC USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Dept Radiat Oncol, Tampa, FL USA
[3] Med Univ South Carolina, Charleston, SC USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2488
引用
收藏
页码：E218 / E218
页数：1
相关论文
共 50 条
  • [31] Spectroscopic output of 125I and 103Pd low dose rate brachytherapy sources
    Usher-Moga, Jacqueline
    Beach, Stephen M.
    DeWerd, Larry A.
    MEDICAL PHYSICS, 2009, 36 (01) : 270 - 278
  • [32] In Vitro Dose Enhancement From Gold Nanoparticles During Low-dose-rate Gamma Irradiation With I-125 Brachytherapy Seeds
    Ngwa, W.
    Korideck, H.
    Kimmelman, A.
    Kassis, A. I.
    Kumar, R.
    Sridhar, S.
    Makrigiorgos, M.
    Cormack, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 84 (03): : S134 - S134
  • [33] Biochemical (prostate-specific antigen) relapse-free survival and toxicity after 125I low-dose-rate prostate brachytherapy
    Khaksar, Sara Jane
    Laing, Robert W.
    Henderson, Alastair
    Sooriakumaran, Prasanna
    Lovell, David
    Langley, Stephen E. M.
    BJU INTERNATIONAL, 2006, 98 (06) : 1210 - 1215
  • [34] In vitro radiosensitization by gold nanoparticles during continuous low-dose-rate gamma irradiation with I-125 brachytherapy seeds
    Ngwa, Wilfred
    Korideck, Houari
    Kassis, Amin I.
    Kumar, Rajiv
    Sridhar, Srinivas
    Makrigiorgos, G. Mike
    Cormack, Robert A.
    NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE, 2013, 9 (01) : 25 - 27
  • [35] Edema associated with I-125 or Pd-103 prostate brachytherapy and its effect on post-implant dosimetry: An analysis based on serial CT acquisition
    Waterman, FM
    Yue, N
    Corn, BW
    Dicker, AP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1997, 39 (02): : 220 - 220
  • [36] Edema associated with I-125 or Pd-103 prostate brachytherapy and its impact on post-implant dosimetry: An analysis based on serial CT acquisition
    Waterman, FM
    Yue, N
    Corn, BW
    Dicker, AP
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1998, 41 (05): : 1069 - 1077
  • [37] New methods for anisotropy characterization of Pd-103 and I-125 prostate brachytherapy seed emissions using radiochromic film and angular x-ray spectrometry
    Mitch, M
    Lamperti, P
    Seltzer, S
    Coursey, B
    MEDICAL PHYSICS, 2002, 29 (06) : 1228 - 1228
  • [38] Dosimetric Study of Dose De-Escalation Using MRIGuidance in Low and Intermediate Risk Prostate Cancer Patients with Pd-103 Low Dose Rate Brachytherapy
    Xue, A.
    Gogineni, A.
    Wang, L.
    Potters, L.
    Bhupesh, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E598 - E599
  • [39] I-125 versus Pd-103 for low-risk prostate cancer: Long-term morbidity outcomes from a prospective randomized multicenter controlled trial
    Herstein, A
    Wallner, K
    Merrick, G
    Mitsuyama, H
    Armstrong, J
    True, L
    Cavanagh, W
    Butler, W
    CANCER JOURNAL, 2005, 11 (05): : 385 - 389
  • [40] Sarcopenia and excess visceral fat accumulation negatively affect early urinary function after I-125 low-dose-rate brachytherapy for localized prostate cancer
    Ogasawara, Naoyuki
    Nakiri, Makoto
    Kurose, Hirofumi
    Ueda, Kosuke
    Chikui, Katsuaki
    Nishihara, Kiyoaki
    Matsuo, Mitsunori
    Suekane, Shigetaka
    Morimatsu, Yoshitaka
    Murotani, Kenta
    Muraki, Koichiro
    Hattori, Chikayuki
    Ogo, Etsuyo
    Ishitake, Tatsuya
    Igawa, Tsukasa
    INTERNATIONAL JOURNAL OF UROLOGY, 2023, 30 (04) : 347 - 355
12345